Literature DB >> 10645229

Measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid tumours: comparison of different methods of assessing vascularity.

N A Wong1, J Willott, M J Kendall, E A Sheffield.   

Abstract

AIMS: To determine whether the measurement of vascularity can be used to differentiate follicular adenomas from follicular carcinomas or to reflect the prognosis of follicular carcinomas and papillary carcinomas of the thyroid gland, and to compare four methods of assessing vascularity.
METHODS: Tissue sections from 26 papillary carcinomas, 15 follicular adenomas, and 15 follicular carcinomas were stained with an antibody to CD34. A computerised image analysis system was used to calculate, for each tumour, mean endothelial areas and the mean endothelium to tumour epithelial nucleus area ratio from 10 systematically selected fields across one dimension of the tumour ("systematic field" analysis) or from the three most vascularised fields of the tumour ("hot spot" analysis). A European Organisation for Research on Treatment of Cancer (EORTC) prognostic index was calculated for each papillary carcinoma and follicular carcinoma.
RESULTS: Significant differences in vascularity between the three tumour groups could only be shown by comparing mean endothelial area values measured from hot spots. While the hot spot median mean endothelial area of follicular carcinomas was significantly greater than that of follicular adenomas, there was a large overlap between the two groups. For follicular carcinomas, higher hot spot mean endothelial area values were related to worse prognosis as indicated by the EORTC prognostic indices. No association between vascularity and prognosis was found for the papillary carcinomas, regardless of the method of assessing vascularity.
CONCLUSIONS: Measuring endothelial area from hot spots using a computerised image analysis system is a sensitive method of assessing the vascularity of thyroid tumours. While vascularity measurement cannot be recommended as a practical tool for differentiating between malignant and benign follicular tumours, the suggestion that vascularity may reflect prognosis for follicular carcinomas deserves further study.

Entities:  

Mesh:

Year:  1999        PMID: 10645229      PMCID: PMC500950          DOI: 10.1136/jcp.52.8.593

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

Review 1.  Tumour angiogenesis and prognosis.

Authors:  S B Fox
Journal:  Histopathology       Date:  1997-03       Impact factor: 5.087

2.  Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density.

Authors:  J D Goldenberg; L G Portugal; B L Wenig; K Ferrer; J C Wu; J Sabnani
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

3.  CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.

Authors:  M Vierbuchen; S Schröder; G Uhlenbruck; M Ortmann; R Fischer
Journal:  Lab Invest       Date:  1989-05       Impact factor: 5.662

4.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

5.  Microvessel density is a prognostic indicator for patients with astroglial brain tumors.

Authors:  S P Leon; R D Folkerth; P M Black
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

6.  Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.

Authors:  G Fontanini; S Vignati; F Pacini; L Pollina; F Basolo
Journal:  Mod Pathol       Date:  1996-06       Impact factor: 7.842

7.  Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas.

Authors:  G Tuccari; G Barresi
Journal:  Histopathology       Date:  1987-07       Impact factor: 5.087

8.  Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?

Authors:  H Goulding; N F Abdul Rashid; J F Robertson; J A Bell; C W Elston; R W Blamey; I O Ellis
Journal:  Hum Pathol       Date:  1995-11       Impact factor: 3.466

9.  A morphometric study of neovascularization in colorectal carcinoma.

Authors:  P M Pavlopoulos; A E Konstantinidou; E Agapitos; N Kavantzas; P Nikolopoulou; P Davaris
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

10.  Novel methods for the determination of the angiogenic activity of human tumors.

Authors:  M Barbareschi; G Gasparini; L Morelli; S Forti; P Dalla Palma
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more
  3 in total

1.  Three-dimensional reconstruction of vessel distribution in benign and malignant lesions of thyroid.

Authors:  Maria P Foschini; Mauro Papotti; Alfredo Parmeggiani; Giovanni Tallini; Luciano Castaldini; Domenico Meringolo; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2004-06-08       Impact factor: 4.064

2.  Analysis of vascularization in thyroid gland nodes with superb microvascular imaging (SMI) and CD34 expression histology: a pilot study.

Authors:  Thomas Studeny; Wolfgang Kratzer; Julian Schmidberger; Tilmann Graeter; Thomas F E Barth; Andreas Hillenbrand
Journal:  BMC Med Imaging       Date:  2021-10-30       Impact factor: 1.930

3.  Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers.

Authors:  Takashi Sugino; Tomiko Yamaguchi; Go Ogura; Atsuko Saito; Takeaki Hashimoto; Nobuo Hoshi; Sayaka Yoshida; Steve Goodison; Toshimitsu Suzuki
Journal:  BMC Med       Date:  2004-04-05       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.